Sigma Speaks: Audio News Daily (Tailored for Retail Investors)

In this episode:

• Markets today: Sep 4
• Broadcom beats expectations as AI labs double down on custom chips
• Lucid’s CEO Promised a $1.4 Billion Turnaround, Then This Happened
• Apple's new CEO, John Ternus, takes over from Tim Cook after 15 years
• PG&E, Rewiring America and Google Launch First-of-its-Kind Virtual Power Plant to Help Lower Costs for All Customers
• Stryker introduces first of its kind FDA-authorized surgical application for Apple Vision Pro with hip arthroscopy case at nationally recognized academic medical center
• The Cybercab is Tesla’s ‘fork in the road’ moment
• Nio opens first Nio House in Macau as ES9 deliveries begin
• Micron Is No Longer What It Was So I Keep Loading Up
• Microsoft to impose time limits on Xbox cloud gaming subscribers as costs continue to climb
• FDA: new drugs and therapies
• Igniting Roman’s Journey
• New ‘connectome’ shows all 124 million contact points in the fruit fly’s nervous system
• Latest updates: BepiColombo's arrival at Mercury
• FDA Issues Emergency Use Authorization for Drugs to Prevent and Treat New World Screwworm in Dogs and Cats
• New type of stainless steel is optimized for hydrogen electrolysis

In this episode:

• Markets today: Sep 3
• Microsoft Discloses Exact Azure Sales Figures For The First Time Following Longstanding Investor Demand
• Apple facing $2.7 billion UK lawsuit over ’unfair’ app tracking rules
• PG&E, Rewiring America and Google Launch First-of-its-Kind Virtual Power Plant to Help Lower Costs for All Customers
• Tesla’s Cybercab event set for Thursday, with few details
• Tesla FSD testing begins in France ahead of EU approval vote
• Parsons Faces Legal Investigation Amid Financial Performance Decline
• Synchrony Financial (SYF) Q2 2025 Earnings: Results, Market Reaction & History
• Earnings call transcript: Broadcom tops Q3 2026 estimates as AI sales surge
• Snowflake spikes 22% on healthy results and AI coding momentum
• FDA: new drugs and therapies
• “Broken heart syndrome” can look just like a heart attack. This test can tell them apart
• Triple-threat WIG hydrofoil aircraft makes maiden flight
• FLEX and Sentinel-3C sealed within Vega-C fairing
• Historic Engines Take Their Place on Artemis III
• Cluster’s encore for reentry science a success

In this episode:

• Markets today: Sep 2
• Eli Lilly to buy Merida Biosciences in deal worth up to US$2.88 billion
• Intuitive Surgical (ISRG) Q2 2025 Earnings: Results, Market Reaction & History
• Archer-Daniels-Midland (ADM) Could Be 44% Undervalued Following Plant Upgrades And Higher Guidance
• Apple enters John Ternus era as AI challenges and memory crunch intensify
• Tesla China sales growth slows to 3.6% in August
• Microsoft’s AI Capex Problem Just Got Harder for Bears to Defend
• Tesla set to hold Cybercab event in Austin, Texas
• ONEOK to Acquire Brazos Midstream's Permian Midland Basin Assets in $4.43 Billion Deal
• SLB Agrees to Buy Kelvion, Whose Cooling Solutions Serve Data Centers, for $4.1B
• FDA: new drugs and therapies
• ESA’s first lunar rover rolls forward
• FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device
• ‘Stunning’ Percolation Proof Solves Decades-Old Puzzle About Phase Transitions
• NASA’s Roman Space Telescope launches to reveal the Universe’s darkest secrets
• US Army to install nuclear micro-reactors on 20 domestic military bases